APA

Cohen M. L., Johnson M. P., Schenck K. W., Susemichel A., Wainscott D. B., Robertson D. W. & Nelson D. L. (19930917). DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities. : The Journal of pharmacology and experimental therapeutics.

Chicago

Cohen M L, Johnson M P, Schenck K W, Susemichel A, Wainscott D B, Robertson D W and Nelson D L. 19930917. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities. : The Journal of pharmacology and experimental therapeutics.

Harvard

Cohen M. L., Johnson M. P., Schenck K. W., Susemichel A., Wainscott D. B., Robertson D. W. and Nelson D. L. (19930917). DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities. : The Journal of pharmacology and experimental therapeutics.

MLA

Cohen M L, Johnson M P, Schenck K W, Susemichel A, Wainscott D B, Robertson D W and Nelson D L. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities. : The Journal of pharmacology and experimental therapeutics. 19930917.